Valuation Compugen Ltd. TEL AVIV STOCK EXCHANGE
Stocks
CGEN
IL0010852080
Biotechnology & Medical Research
|
Market Closed -
TEL AVIV STOCK EXCHANGE
07:24:47 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 728.90 ILa | 0.00% |
|
+2.22% | +55.75% |
| 08-03 | Compugen Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-03 | Compugen Ltd., Q2 2026 Earnings Call, Aug 03, 2026 |
Company Valuation: Compugen Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 370.7 | 62 | 174.9 | 137 | 143.1 | 218.8 | - | - |
| Change | - | -83.28% | 182.09% | -21.67% | 4.47% | 52.9% | - | - |
| Enterprise Value (EV) | 370.7 | 62 | 174.9 | 137 | 143.1 | 218.8 | 218.8 | 218.8 |
| Change | - | -83.28% | 182.09% | -21.67% | 4.47% | 52.9% | 0% | 0% |
| P/E | -10.5x | -1.84x | -9.43x | -9.56x | 4.03x | -8.25x | -8.37x | -8.68x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.38x | 0.2x | 0.4x | -0x | 0x | 5.86x | 2.4x |
| Capitalization / Revenue | 61.8x | 8.27x | 5.23x | 4.92x | 1.97x | 23.7x | 28.2x | 12.1x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 23.7x | 28.2x | 12.1x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | 0x | -7.3x | -7.93x | -7.5x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.41 | -0.39 | -0.21 | -0.16 | 0.38 | -0.28 | -0.276 | -0.266 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 6 | 7.5 | 33.46 | 27.86 | 72.76 | 9.239 | 7.75 | 18.02 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -35.07 | -35.37 | -12.99 | -14.89 | 31.33 | -29.97 | -27.58 | -29.19 |
| Net income 1 | -34.2 | -33.69 | -18.75 | -14.23 | 35.34 | -26.46 | -26.95 | -26.63 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 4.300 | 0.716 | 1.980 | 1.530 | 1.530 | 2.310 | 2.310 | 2.310 |
| Nbr of stocks (in thousands) | 86,214 | 86,625 | 88,327 | 89,536 | 93,535 | 94,724 | - | - |
| Announcement Date | 2/24/22 | 2/27/23 | 3/5/24 | 3/4/25 | 3/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 20.98x | 31.37x | 12.47x | 0.31% | 43.39B | |
| Weighted average by Cap. | 22.27x | 32.04x | 13.55x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CGEN Stock
- CGEN Stock
- Valuation Compugen Ltd.
Select your edition
All financial news and data tailored to specific country editions
